At first, ABCG2 is critical in removing excess cholesterol [6–9]; the loss of function variant in the ABCG2 gene (rs2231142) leads to the inhibition of ABCG2 function [12, 13], thus resulting in dyslipidemia. This evidence concerns the gene ABCG2 and metabolic syndrome.